Skip to main content
Clinical Trials/ACTRN12620000381987
ACTRN12620000381987
Not yet recruiting
未知

A brief illness perception intervention to improve adherence and glycemic control in patients with type 2 diabetes: A randomised controlled trial

Professor Elizabeth Broadbent0 sites126 target enrollmentMarch 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
Professor Elizabeth Broadbent
Enrollment
126
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 20, 2020
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Elizabeth Broadbent

Eligibility Criteria

Inclusion Criteria

  • Patients with poorly controlled type 2 diabetes will be included in this trial if they are (1\) over 18 years of age (2\) have type 2 diabetes for 1 year and longer (3\) have poor glycaemic control (defined as glycosylated haemoglobin (A1c) concentration greater than or equal to 64 mmol/mol or 8% in the last two readings), and (4\) are prescribed Metformin.
  • Any participating family members will have to be over the age of 18 years.

Exclusion Criteria

  • Patients will be excluded if they are (1\) pregnant (2\) have life\-threatening illness (e.g. cancer), and (3\) not prescribed Metformin.

Outcomes

Primary Outcomes

Not specified

Similar Trials